Cancer BiologyNature CommunicationsPeer-reviewed
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia
Florian Märkl, Christoph Schultheiß, Murtaza Ali…·Mascha Binder
This study develops CAR T cells targeting a specific mutation in CLL to selectively kill cancer cells while sparing healthy B cells.
15 citations